Cochrane Collaboration, zinc taken as a lozenge or syrup reduced the duration and severity of the common cold in healthy people. "People taking zinc are also less likely to have persistence of their cold symptoms beyond seven days of treatment. Zinc supplementation for at least five months reduces incidence, school absenteeism and prescription of antibiotics for children with the common cold."" /> Cochrane Collaboration, zinc taken as a lozenge or syrup reduced the duration and severity of the common cold in healthy people. "People taking zinc are also less likely to have persistence of their cold symptoms beyond seven days of treatment. Zinc supplementation for at least five months reduces incidence, school absenteeism and prescription of antibiotics for children with the common cold."" /> Zinc fights the common cold - MINING.COM

Zinc fights the common cold

Zinc may be good for your everyday galvanizing and diecasting, but it may also be good at fighting colds.

According to the Cochrane Collaboration, zinc taken as a lozenge or syrup reduced the duration and severity of the common cold in healthy people.

“People taking zinc are also less likely to have persistence of their cold symptoms beyond seven days of treatment. Zinc supplementation for at least five months reduces incidence, school absenteeism and prescription of antibiotics for children with the common cold.”

The Cochrane Collaboration says that the common cold is one of the most widespread illnesses and is a leading cause of visits to the doctor and absenteeism from school and work.

“Zinc administered within 24 hours of onset of symptoms reduces the duration and severity of the common cold in healthy people. When supplemented for at least five months, it reduces cold incidence, school absenteeism and prescription of antibiotics in children. There is potential for zinc lozenges to produce side effects. In view of this and the differences in study populations, dosages, formulations and duration of treatment, it is difficult to make firm recommendations about the dose, formulation and duration that should be used.”

Michael McCrae wrote this story. You can contact him at [email protected].

Comments